A. Oliver Sartor, M.D., is a medical oncologist at Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota. Dr. Sartor treats advanced prostate cancer and is a global expert in the use of new drugs to treat metastatic disease, including radiopharmaceuticals. He has been a principal or co-principal investigator on four pivotal multi-institutional clinical trials leading to Food and Drug Administration approvals for new drugs to treat advanced prostate cancer. As the chair of the Genitourinary Cancer Disease Group and director of Radiopharmaceutical Clinical Trials across the enterprise for Mayo Clinic Comprehensive Cancer Center, Dr. Sartor focuses predominantly on clinical and translational aspects of prostate cancer. Mayo Clinic is the #1 hospital in the nation, according to the U.S. News & World Report, and the Cancer Center continually ranks among the top hospitals in the U.S. for cancer.